Table 3

Summary of the results of all fitted models evaluating the association of seasons (winter vs summer) with the outcomes while controlling for different covariates

Covariates*Outcomes of all fitted modelsOR95% CIp Value
Season: winter vs summerBASDAImoderate-severe vs BASDAIminimal-moderate0.850.34 to 2.130.725
BASDAI as a continuous variable (1 unit increase)1.050.44 to 2.490.918
PGAfair-very poor vs PGAgood-very good1.390.99 to 1.940.056
PASImild-severe vs PASIremission-minimal1.090.81 to 1.460.584
PASI as a continuous variable (1 unit increase)2.160.95 to 4.910.065
  • * All models included the same covariates, namely: season (winter vs summer), age (1-year increase), sex (males vs females), duration of psoriatic arthritis at first visit (1-year increase), calendar time (one decade increase), biologics (yes vs no), disease-modifying antirheumatic drugs (yes vs no), non-steroidal anti-inflammatory drugs (yes vs no) and ultraviolet therapy (yes vs no).

  • BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; PASI, Psoriasis Area and Severity Index; PGA, patient global assessment.